申请人:ASTRAZENECA AB
公开号:US20140357661A1
公开(公告)日:2014-12-04
The invention concerns compounds of Formula (I)
or pharmaceutically-acceptable salts thereof, wherein R
1
to R
5
have any of the meanings defined hereinbefore in the description: processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.
该发明涉及公式(I)的化合物或其药用盐,其中R1至R5具有在描述中定义的任何含义:它们的制备方法,含有它们的药物组合物以及它们在治疗细胞增殖性疾病中的用途。